Skip to main content Skip to main navigation menu Skip to site footer
Journal of Commercial Biotechnology
  1. Home /
  2. Archives /
  3. Vol. 22 No. 2 (2016)

Vol. 22 No. 2 (2016)

Published: 2016-08-30

Commentary

  • Of Pens, Pizzas, and Pharmaceuticals

    Peter J. Pitts
    • Requires Subscription PDF (USD 25)

Article

  • Intellectual Property Business Models Using Patent Acquisition: A Case Study of Royalty Pharma Inc.

    Su Young Lim, Minsuk Suh
    • Requires Subscription PDF (USD 25)
  • Manage Complexity and Uncertainty in Biotechnological Innovations: Converting Theoretical Advances into Opportunities

    Jonathan Baert
    • Requires Subscription PDF (USD 25)
  • The Chinese medical device market: Market drivers and investment prospects

    Weifan Zhang, Rebecca Liu, Chris Chatwin
    • Requires Subscription PDF (USD 25)
  • Investor experience in biotechnology

    William Bains, Daniel Rabbie, Weiyi Yao, David Ricardo Munoz Guzman
    • Requires Subscription PDF (USD 25)
  • The BIEM Verification Study: Experienced Venture Capitalists Assess a Biopharmaceuticals Innovation Expertise Model

    Moira A. Gunn, Nola Masterson, Paul Lorton, Jr., Jacques Baronet
    • Requires Subscription PDF (USD 25)

Intellectual Property Management

  • Recent Developments in Compulsory Licensing of Pharmaceutical Patents in India

    Viren Konde
    • Requires Subscription PDF (USD 25)

Legal and Regulatory Updates

  • Post-Grant Review of U.S. Patents: A Primer

    Stefan Michael Miller, Gregory R. Springsted
    • Requires Subscription PDF (USD 25)

Conference Report

  • Technology Commercialization & Partnerships for Global Health

    Vasu Pestonjamasp
    • Requires Subscription PDF (USD 25)

Copyright © 2021
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

Journal of Commercial Biotechnology

GoDaddy SiteSeal WebTrust